Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 68.00
+2.25 (3.42%)
At close: Jun 1, 2026
Invicta Diagnostic Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 323.54 | 300.95 | 158.31 | 68.43 | 29.03 |
Other Revenue | 6.88 | 0.86 | 0.68 | - | - |
| 330.42 | 301.81 | 158.98 | 68.43 | 29.03 | |
Revenue Growth (YoY) | 9.48% | 89.84% | 132.33% | 135.74% | - |
Cost of Revenue | 27.25 | 23.63 | 14.67 | 9.56 | 7.93 |
Gross Profit | 303.17 | 278.18 | 144.32 | 58.87 | 21.1 |
Selling, General & Admin | 48.91 | 74.9 | 35.15 | 18.67 | 2.8 |
Other Operating Expenses | 149.74 | 110.44 | 37.62 | 23 | 15.55 |
Operating Expenses | 231.13 | 210.24 | 92.1 | 60.68 | 49.51 |
Operating Income | 72.04 | 67.94 | 52.22 | -1.81 | -28.41 |
Interest Expense | -1.95 | -1.61 | -0.59 | - | - |
Interest & Investment Income | - | - | - | 0.11 | 2.14 |
Other Non Operating Income (Expenses) | -0 | -0.7 | -0.42 | - | 0.03 |
EBT Excluding Unusual Items | 70.08 | 65.64 | 51.21 | -1.7 | -26.24 |
Gain (Loss) on Sale of Investments | - | - | - | -0 | - |
Pretax Income | 70.08 | 65.64 | 51.21 | -1.71 | -26.24 |
Income Tax Expense | 21.35 | 16.34 | 13.16 | - | - |
Earnings From Continuing Operations | 48.73 | 49.3 | 38.05 | -1.71 | -26.24 |
Minority Interest in Earnings | 0.33 | -0.38 | -0.44 | - | - |
Net Income | 49.06 | 48.92 | 37.61 | -1.71 | -26.24 |
Net Income to Common | 49.06 | 48.92 | 37.61 | -1.71 | -26.24 |
Net Income Growth | 0.30% | 30.04% | - | - | - |
Shares Outstanding (Basic) | 10 | 8 | 8 | - | - |
Shares Outstanding (Diluted) | 10 | 8 | 8 | - | - |
Shares Change (YoY) | 18.95% | - | - | - | - |
EPS (Basic) | 4.90 | 5.81 | 4.47 | - | - |
EPS (Diluted) | 4.90 | 5.81 | 4.47 | - | - |
EPS Growth | -15.68% | 30.04% | - | - | - |
Free Cash Flow | -100.29 | 60.03 | -21.16 | - | - |
Free Cash Flow Per Share | -10.02 | 7.13 | -2.51 | - | - |
Gross Margin | 91.75% | 92.17% | 90.77% | 86.03% | 72.68% |
Operating Margin | 21.80% | 22.51% | 32.84% | -2.65% | -97.88% |
Profit Margin | 14.85% | 16.21% | 23.66% | -2.50% | -90.40% |
Free Cash Flow Margin | -30.35% | 19.89% | -13.31% | - | - |
EBITDA | 104.51 | 92.81 | 71.43 | 17.21 | 2.75 |
EBITDA Margin | 31.63% | 30.75% | 44.93% | 25.15% | 9.47% |
D&A For EBITDA | 32.47 | 24.87 | 19.21 | 19.02 | 31.16 |
EBIT | 72.04 | 67.94 | 52.22 | -1.81 | -28.41 |
EBIT Margin | 21.80% | 22.51% | 32.84% | -2.65% | -97.88% |
Effective Tax Rate | 30.47% | 24.90% | 25.69% | - | - |
Revenue as Reported | 330.42 | 301.81 | 158.98 | 68.54 | 31.2 |
Advertising Expenses | - | 10.84 | 5.05 | 4.42 | - |